Omalizumab in patients with severe asthma and persistent sputum eosinophilia
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1710-1492
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Omalizumab in patients with severe asthma and persistent sputum eosinophilia ; volume:15 ; number:1 ; day:3 ; month:4 ; year:2019 ; pages:1-5 ; date:12.2019
Allergy, asthma and clinical immunology ; 15, Heft 1 (3.4.2019), 1-5, 12.2019
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Mukherjee, Manali
Kjarsgaard, Melanie
Radford, Katherine
Huang, Chynna
Leigh, Richard
Dorscheid, Delbert R.
Lemiere, Catherine
Boulet, Louis-Philippe
Waserman, Susan
Martin, James
Nair, Parameswaran
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13223-019-0337-2
- URN
-
urn:nbn:de:101:1-2019042401225232753501
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mukherjee, Manali
- Kjarsgaard, Melanie
- Radford, Katherine
- Huang, Chynna
- Leigh, Richard
- Dorscheid, Delbert R.
- Lemiere, Catherine
- Boulet, Louis-Philippe
- Waserman, Susan
- Martin, James
- Nair, Parameswaran
- SpringerLink (Online service)
Ähnliche Objekte (12)
Blood and sputum eosinophilia in COPD exacerbation
Underestimation of airway luminal eosinophilia by quantitative sputum cytometry
Severe asthma and the omalizumab option
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer
Sputum-ECP bei Asthma bronchiale
Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis
Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
Autoinflammatory gene mutations associated with eosinophilia and asthma
PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab
Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma
Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung
Blood and sputum eosinophilia in COPD exacerbation
Underestimation of airway luminal eosinophilia by quantitative sputum cytometry
Severe asthma and the omalizumab option
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer
Sputum-ECP bei Asthma bronchiale
Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis
Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
Autoinflammatory gene mutations associated with eosinophilia and asthma
PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab
Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma
Omalizumab-Therapie bei Jugendlichen mit schwerem allergischen Asthma – eine Anwendungsbeobachtung
Blood and sputum eosinophilia in COPD exacerbation
Underestimation of airway luminal eosinophilia by quantitative sputum cytometry
Severe asthma and the omalizumab option
4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
A sputum bioassay for airway eosinophilia using an eosinophil peroxidase aptamer
Sputum-ECP bei Asthma bronchiale
Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis
Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry
Autoinflammatory gene mutations associated with eosinophilia and asthma
PD49 - Induced sputum versus exhaled nitric oxide for the evaluation of airway inflammation in allergic pediatric asthma patients treated with omalizumab
Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma